The common side effects of semaglutide: what to expect and when to act

The GI effects most people experience, and why they happen

Semaglutide (the active ingredient in Wegovy) slows gastric emptying and acts on appetite-signalling pathways in the brain. Both mechanisms are central to how it supports weight loss, and both are also why the digestive system takes time to adapt. Nausea is the most commonly reported effect, in the STEP 1 trial published in the New England Journal of Medicine, around 44% of participants on semaglutide 2.4mg reported nausea, compared with 16% on placebo.

Other GI effects include diarrhoea, constipation, bloating, burping and acid reflux. Vomiting occurs in a smaller proportion of people. Fatigue and headache also appear in trial data, though less consistently. The pattern is fairly predictable: symptoms are most noticeable in the first few weeks and after each dose step. Many people find them manageable with simple adjustments, eating smaller portions, avoiding very rich or fatty food, and slowing down at mealtimes. If you want practical strategies for tiredness specifically, the guide to managing fatigue on Wegovy covers what tends to help.

It is worth knowing that the side-effect profile of semaglutide is broadly consistent whether the medicine is injected or taken as a tablet, the full Wegovy side effects overview covers both forms in more detail.

When side effects are a reason to pause, and when to call for help now

This is the section most worth reading carefully. The majority of side effects are not dangerous, but a small number of symptoms need prompt attention rather than watchful waiting.

Seek urgent medical help if you develop severe, persistent stomach pain, particularly pain that radiates to the back, with or without vomiting. This can be a sign of acute pancreatitis. In January 2026 the MHRA's Drug Safety Update formally highlighted acute pancreatitis as a known, if uncommon, risk with GLP-1 receptor agonists including semaglutide, and reminded clinicians and patients to treat this symptom seriously.

Other situations that warrant medical contact without delay: signs of an allergic reaction (swelling of the face, lips or throat; difficulty breathing; rapid heartbeat); symptoms suggesting gallbladder problems (sharp pain in the upper right abdomen, fever, yellowing of the skin); and any signs of significant dehydration from repeated vomiting or diarrhoea, such as dizziness on standing, very dark urine or inability to keep fluids down. If you experience new or worsening low mood or thoughts of self-harm, contact your GP or call 111. Stop treatment and seek advice, do not simply wait for the next scheduled dose.

If you are unsure whether what you are experiencing is normal, the aftercare team at nume is available seven days a week.

The side effects that are less often talked about

Beyond the GI picture, a few other effects appear in semaglutide trial and post-marketing data and are worth being aware of. Injection-site reactions (redness, itching or mild bruising at the injection site) occur in a minority of people and usually resolve quickly; rotating the site each week helps. Dizziness is reported occasionally, and for people who are also taking diabetes medication, hypoglycaemia (low blood sugar) is a relevant risk to discuss with the prescriber before starting.

Hair thinning is raised by some patients during rapid weight loss. Current understanding is that this reflects the physiological stress of significant calorie reduction rather than a direct drug effect, and it typically resolves. It is the kind of question our prescribers hear regularly, and it is a good example of why an open consultation matters, not just a checklist.

For a more granular breakdown of less common and rare effects, the complete semaglutide side effects resource goes deeper, including effects relevant to specific health conditions. You can also explore what patients report about side effects from semaglutide in broader clinical context.

Making the decision: what the side-effect picture actually tells you

Here is the honest framing. For most people, the first four to eight weeks involve some digestive discomfort. For many, that passes. For a smaller group, it does not settle sufficiently, and they and their prescriber decide together to stop or change approach. Neither outcome is a failure, the point of clinical assessment is to catch contraindications before they become problems, and of ongoing review is to catch them if they emerge.

The decision is not really "is semaglutide side-effect-free?" (it is not). The question is whether the profile is manageable for you, given your health history and the benefit you are hoping for. That is a clinical conversation, not one that belongs on a product page.

At nume, the consultation is reviewed the same day by a GPhC-registered Independent Prescriber (a named clinician, not automated screening) who considers your full picture before any treatment is approved. Side effects, your current medicines, and what to watch for are part of that conversation. If you want to understand the cost side of treatment before deciding, Wegovy pricing in the UK sets out what is typically included. And if you are ready to find out whether semaglutide is clinically suitable for you, start your free consultation, there is no obligation and no upfront charge.